Aruvant Employee Directory

Biotechnology ResearchNew York, United States2-10 Employees

Aruvant is a biotechnology research company focused on developing gene therapies for rare diseases, with a near-term emphasis on sickle cell disease. Its lead candidate, ARU-1801, is an investigational lentiviral gene therapy in clinical testing as a potential one-time cure for sickle cell disease, with preliminary clinical data from the ongoing Phase 1/2 study demonstrating durable efficacy. The program is advancing toward a pivotal trial, and the company relies on a team with experience across development, manufacturing and potential commercialization of gene therapies within the Roivant family.
Aruvant is based in New York City, New York, and operates as a small firm focused on advancing its research program. Public reporting in 2022 noted a leadership transition with the departure of its chief executive in October.

Sign up for free to view info

Company overview Email format